Sign In
Get Clay Free →

Suggestions

    Raphaël Ognar

    Oncology/Hematology Biotech and Pharma C-Suite Executive leader, specialized in Cell Therapy and Immuno-Oncology.

    Raphaël G. Ognar is the President, CEO, and Co-Founder of NKILT Therapeutics, a biotech company he established in July 2021.3 He is an experienced pharma/biotech executive with over 25 years of expertise in commercial, drug development, product lifecycle, and strategy, particularly in oncology and hematology.14

    Ognar has a strong background in immuno-oncology and cell therapy technologies. He holds a Masters and D.E.A. of Physiology and Neurosciences from the University of Bordeaux I&II, and an MBA in Strategic Marketing and Enterprise Management from I.A.E Tours University.14

    Career Highlights

    • Founded ANIM8 LLC in 2018, an executive strategy & operations consulting company supporting early-stage biotechs13
    • Co-founded NKILT Therapeutics in 2021 to develop a novel allogeneic cell therapy technology1
    • Held senior positions at companies such as Bristol Myers Squibb, Celgene, and Novartis Oncology3
    • Served as Senior Vice President Global Oncology/Hematology and C&GT Solutions at Alira Health from March 2022 to April 20233

    NKILT Therapeutics

    NKILT Therapeutics is developing a new binding approach for allogeneic cell therapy, targeting an understudied target called H-lag using a Chimeric ILT Receptor (CILR) concept.2 As of January 2025, the company is in the pre-seed funding stage and has recently opened its labs.2

    Personal Interests

    Outside of his professional life, Raphaël Ognar is passionate about vintage wines, playing music in his family band, rock climbing with his wife, and traveling the world with friends and family.14

    Highlights

    Raphaël G. Ognar, MBA, MSc - Life Science Success

    Related Questions

    What inspired Raphaël Ognar to start NKILT Therapeutics?
    How does NKILT Therapeutics' technology differ from other cell therapies?
    What are the main challenges Raphaël Ognar has faced in his career?
    Can you tell me more about the HLAG target that NKILT Therapeutics is focusing on?
    What role did Raphaël Ognar's background in oncology play in founding NKILT Therapeutics?
    Raphaël Ognar
    Add to my network

    Location

    Springfield, New Jersey, United States